E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/9/2016 in the Prospect News PIPE Daily.

21st Century Oncology settles $25 million convertible preferreds sale

Preferreds sold at $1,000 each to Canada Pension Plan Investment Board

By Devika Patel

Knoxville, Tenn., Sept. 9 – 21st Century Oncology Holdings, Inc. completed a $25 million private placement of series A convertible preferred stock with Canada Pension Plan Investment Board on Sept. 9, according to an 8-K filed Tuesday with the Securities and Exchange Commission.

The company sold 25,000 preferreds at $1,000 apiece.

Each preferred is mandatorily convertible into common stock.

The Fort Meyers, Fla., company offers cancer treatment services.

Issuer:21st Century Oncology Holdings, Inc.
Issue:Series A convertible preferred stock
Amount:$25 million
Shares:25,000
Price:$1,000
Warrants:No
Investor:Canada Pension Plan Investment Board
Settlement date:Sept. 9
Stock symbol:NYSE: ICC

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.